Literature DB >> 21160856

Minute liver metastases from a rectal carcinoid: A case report and review.

Hirofumi Yamamoto1, Hideyuki Hemmi, Jin-Yu Gu, Mitsugu Sekimoto, Yuichiro Doki, Masaki Mori.   

Abstract

We here report a 43-year-old male patient with minute liver metastases from a rectal carcinoid. Hepatic nodules were diagnosed during surgery, although they were not diagnosed by preoperative computed tomography or ultrasound examination. The rectal carcinoid was resected together with liver metastases and the patient has had no disease recurrence for 5 years following postoperative treatment of hepatic arterial infusion chemotherapy (HAIC) using 5-fluorouracil (5-FU) and oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU). In 2003, a health check examination indicated presence of occult blood in his stool. Barium enema study revealed a rectal tumor in the lower rectum and colonoscopy showed a yellowish lesion with a size of 30 mm in diameter. Pathological examination of the biopsy specimen indicated that the rectal tumor was carcinoid. Although preoperative imaging examinations failed to detect liver metastases, 2 min nodules were found on the surface of liver during surgery. A rapid pathological examination revealed that they were metastatic tumors from the rectal carcinoid. Low anterior resection was performed for the rectal tumor and the pathological report indicated that there were 4 metastatic lymph nodes in the rectal mesentery. The patient received treatment by HAIC using 5-FU plus oral administration of HCFU and survived for 5 years.We also review world-wide current treatments and their efficacy for hepatic metastases of carcinoid tumors.

Entities:  

Keywords:  5-Fluorouracil; Hepatic arterial infusion chemotherapy; Liver metastasis; Rectal carcinoid

Year:  2010        PMID: 21160856      PMCID: PMC2999217          DOI: 10.4240/wjgs.v2.i3.89

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  35 in total

1.  Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.

Authors:  B Wängberg; G Westberg; U Tylén; L Tisell; S Jansson; O Nilsson; V Johansson; T Scherstén; H Ahlman
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

2.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

3.  Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.

Authors:  Y H Kim; J A Ajani; C H Carrasco; P Dumas; W Richli; D Lawrence; V Chuang; S Wallace
Journal:  Cancer Invest       Date:  1999       Impact factor: 2.176

4.  Aggressive surgery for metastatic liver neuroendocrine tumors.

Authors:  Jeffrey A Norton; Robert S Warren; Mary G Kelly; Marlene B Zuraek; Robert T Jensen
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

5.  Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group.

Authors:  E Bajetta; N Zilembo; M Di Bartolomeo; A Di Leo; S Pilotti; A M Bochicchio; R Castellani; R Buzzoni; L Celio; L Dogliotti
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

6.  Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases.

Authors:  E Crocetti; E Paci
Journal:  Eur J Cancer Prev       Date:  2003-06       Impact factor: 2.497

7.  Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.

Authors:  M di Bartolomeo; E Bajetta; R Buzzoni; L Mariani; C Carnaghi; L Somma; N Zilembo; A di Leo
Journal:  Cancer       Date:  1996-01-15       Impact factor: 6.860

8.  Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

Authors:  P Ruszniewski; P Rougier; A Roche; P Legmann; A Sibert; S Hochlaf; M Ychou; M Mignon
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

9.  Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.

Authors:  A Chiti; S Fanti; G Savelli; A Romeo; B Bellanova; M Rodari; B J van Graafeiland; N Monetti; E Bombardieri
Journal:  Eur J Nucl Med       Date:  1998-10

Review 10.  Neuroendocrine metastases of the liver.

Authors:  I Ihse; B Persson; S Tibblin
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more
  1 in total

1.  Management of sub-5 mm rectal carcinoids with lymph node metastases.

Authors:  James Wei Tatt Toh; Christopher Henderson; Takako Eva Yabe; Evonne Ong; Pierre Chapuis; Les Bokey
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.